Dolby Laboratories Stock Price Target and Analyst Ratings (NYSE:DLB)

Analyst Price Target for DLB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$79.00

▼ -20.83% Downside Potential

This price target is based on 4 analysts offering 12 month price targets for Dolby Laboratories in the last 3 months. The average price target is $79.00, with a high forecast of $89.00 and a low forecast of $65.00. The average price target represents a -20.83% upside from the last price of $99.78.

Buy

The current consensus among 4 polled investment analysts is to buy stock in Dolby Laboratories. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
2 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

10/28/2019

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

1/26/2020

0 strong buy ratings
4 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/25/2020

0 strong buy ratings
4 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

7/24/2020

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

10/22/2020

0 strong buy ratings
2 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

1/20/2021

0 strong buy ratings
2 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/21/2021

0 strong buy ratings
2 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/20/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/25/2021	Tigress Financial	Reiterated Rating	Buy		Low	i
1/29/2021	B. Riley	Boost Price Target	Neutral	$79.00 ➝ $89.00	High	i
1/26/2021	Barrington Research	Downgrade	Outperform ➝ Market Perform		High	i Rating by J. Goss at Barrington Research
1/4/2021	Barrington Research	Downgrade	Outperform ➝ Market Perform		N/A	i
11/13/2020	B. Riley	Boost Price Target	Neutral	$73.00 ➝ $79.00	High	i Rating by E. Wold at B. Riley
8/5/2020	Barrington Research	Boost Price Target	Outperform	$70.00 ➝ $83.00	Low	i
8/4/2020	B. Riley	Boost Price Target	Neutral	$72.00 ➝ $73.00	High	i Rating by E. Wold at B. Riley
6/24/2020	B. Riley	Downgrade	Buy ➝ Neutral	$68.00 ➝ $72.00	High	i Rating by Eric Wold at B. Riley
5/29/2020	B. Riley	Reiterated Rating	Buy	$68.00	Low	i Rating by Eric Wold at B. Riley
5/5/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$66.00 ➝ $65.00	High	i
5/5/2020	B. Riley	Lower Price Target	Buy	$71.00 ➝ $68.00	High	i Rating by Eric Wold at B. Riley
4/15/2020	B. Riley	Reiterated Rating	Buy	$60.00 ➝ $71.00	Low	i Rating by Eric Wold at B. Riley
3/26/2020	Barrington Research	Lower Price Target	Positive ➝ Outperform	$85.00 ➝ $70.00	Medium	i Rating by James Goss at Barrington Research
3/24/2020	B. Riley	Upgrade	Neutral ➝ Buy	$57.00 ➝ $60.00	High	i Rating by Eric Wold at B. Riley
3/18/2020	B. Riley	Lower Price Target	Neutral	$71.00 ➝ $57.00	High	i Rating by E. Wold at B. Riley
3/13/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$66.00 ➝ $66.00	High	i
3/9/2020	Tigress Financial	Reiterated Rating	Buy		High	i Rating by Ivan Feinseth at Tigress Financial
1/30/2020	Barrington Research	Reiterated Rating	Buy		Low	i Rating by James Goss at Barrington Research
1/10/2020	B. Riley	Downgrade	Buy ➝ Neutral	$73.00	Low	i Rating by E. Wold at B. Riley
11/21/2019	Barrington Research	Reiterated Rating	Buy	$85.00	Low	i Rating by James Goss at Barrington Research
11/11/2019	Dougherty & Co	Reiterated Rating	Buy		Medium	i Rating by S. Frankel at Dougherty & Co
11/11/2019	B. Riley	Upgrade	Neutral ➝ Buy	$73.00	Medium	i Rating by E. Wold at B. Riley
9/18/2019	Tigress Financial	Reiterated Rating	Buy		Low	i
8/2/2019	William Blair	Reiterated Rating	Buy		Low	i Rating by Ralph Schackart at William Blair
8/2/2019	B. Riley	Upgrade	Neutral ➝ Buy		High	i Rating by Eric Wold at B. Riley
8/2/2019	B. Riley	Reiterated Rating	Neutral ➝ Neutral	$67.00 ➝ $73.00	High	i Rating by Eric Wold at B. Riley
6/13/2019	B. Riley	Set Price Target	Hold	$67.00	Low	i Rating by Eric Wold at B. Riley
1/31/2019	Barrington Research	Reiterated Rating	Buy	$85.00	High	i
12/4/2018	B. Riley	Set Price Target	Hold	$67.00	High	i Rating by Eric Wold at B. Riley
10/25/2018	B. Riley	Lower Price Target	Neutral	$69.00 ➝ $63.00	High	i
10/22/2018	R. F. Lafferty	Lower Price Target	Buy ➝ Buy	$81.00 ➝ $80.00	Low	i
9/7/2018	Tigress Financial	Reiterated Rating	Buy		Low	i
9/5/2018	R. F. Lafferty	Initiated Coverage	Buy	$81.00	Low	i
7/26/2018	Barrington Research	Reiterated Rating	Buy	$78.00	High	i
7/26/2018	B. Riley	Boost Price Target	Neutral	$61.00 ➝ $69.00	High	i
5/1/2018	Barrington Research	Reiterated Rating	Buy	$78.00	Low	i
1/25/2018	B. Riley	Downgrade	Hold	$63.00	High	i Rating by E. Wold at B. Riley
1/25/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$63.00 ➝ $70.00	Medium	i
1/16/2018	B. Riley	Downgrade	Buy ➝ Neutral	$63.00 ➝ $63.00	High	i Rating by Eric Wold at B. Riley
10/26/2017	B. Riley	Reiterated Rating	Buy	$65.50	N/A	i Rating by Eric Wold at B. Riley
10/19/2017	B. Riley	Set Price Target	Buy	$61.50 ➝ $66.00	N/A	i Rating by Eric Wold at B. Riley
9/14/2017	B. Riley	Reiterated Rating	Buy	$61.50	Low	i Rating by Eric Wold at B. Riley
9/13/2017	Dougherty & Co	Reiterated Rating	Buy	$63.00	Low	i
9/13/2017	Piper Jaffray Companies	Reiterated Rating	Hold	$49.00 ➝ $52.00	High	i
8/23/2017	B. Riley	Reiterated Rating	DLB (	$61.50	Low	i Rating by Eric Wold at B. Riley
8/18/2017	B. Riley	Reiterated Rating	DLB (	$61.50	Low	i Rating by Eric Wold at B. Riley
8/18/2017	B. Riley	Set Price Target	Buy	$62.00	Low	i Rating by Eric Wold at B. Riley
7/28/2017	B. Riley	Reiterated Rating	Buy	$61.50	Low	i Rating by E. Wold at B. Riley
7/22/2017	B. Riley	Upgrade	Buy	$61.50	Low	i Rating by E. Wold at B. Riley
7/17/2017	B. Riley	Upgrade	Neutral ➝ Buy	$57.00 ➝ $61.50	High	i Rating by E. Wold at B. Riley
4/30/2017	B. Riley	Reiterated Rating	Neutral	$57.00	Medium	i
4/25/2017	B. Riley	Reiterated Rating	Neutral	$52.00 ➝ $57.00	Low	i
1/28/2017	B. Riley	Initiated Coverage	Neutral	$52.00	N/A	i
1/26/2017	Piper Jaffray Companies	Reiterated Rating	Hold		N/A	i
1/23/2017	B. Riley	Reiterated Rating	Neutral	$49.00	N/A	i Rating by Eric Wold at B. Riley
1/20/2017	Piper Jaffray Companies	Reiterated Rating	Hold	$46.00	N/A	i
11/1/2016	B. Riley	Reiterated Rating	Neutral	$49.00	N/A	i Rating by Eric Wold at B. Riley
10/27/2016	B. Riley	Reiterated Rating	Neutral	$49.00	N/A	i Rating by Eric Wold at B. Riley
10/27/2016	Barrington Research	Upgrade	Market Perform ➝ Outperform		N/A	i Rating by J. Goss at Barrington Research
10/21/2016	B. Riley	Initiated Coverage	Neutral	$50.00	N/A	i Rating by Eric Wold at B. Riley
10/4/2016	JPMorgan Chase & Co.	Initiated Coverage	Neutral	$51.00	N/A	i Rating by Paul Coster at JPMorgan Chase & Co.
8/2/2016	B. Riley	Reiterated Rating	Neutral	$50.00	N/A	i Rating by Eric Wold at B. Riley
7/28/2016	B. Riley	Set Price Target	Hold	$50.00	N/A	i Rating by Eric Wold at B. Riley
7/28/2016	Dougherty & Co	Boost Price Target	Buy	$54.00 ➝ $57.00	N/A	i Rating by Steve Frankel at Dougherty & Co
7/25/2016	B. Riley	Reiterated Rating	Neutral	$46.00	N/A	i
5/3/2016	B. Riley	Reiterated Rating	Neutral	$46.00	N/A	i
5/1/2016	Piper Jaffray Companies	Reiterated Rating	Neutral	$43.00	N/A	i
4/28/2016	B. Riley	Reiterated Rating	Neutral	$46.00	N/A	i
4/25/2016	Dougherty & Co	Reiterated Rating	Buy	$38.00 ➝ $46.00	N/A	i Rating by Steve Frankel at Dougherty & Co

(Data available from 4/21/2016 forward)

Dolby Laboratoties, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries. Its products include Cinema Imaging, Cinema Audio, Dolby Conference Phone, Dolby Voice Room, and Other Products. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.

Today's Range

Now: $99.78

$99.58

$99.90

50 Day Range

MA: $99.93

$96.09

$103.19

52 Week Range

Now: $99.78

$52.13

$103.88

Volume

189 shs

Average Volume

497,405 shs

Market Capitalization

$10.14 billion

P/E Ratio

44.35

Dividend Yield

0.87%

Beta

0.89

Frequently Asked Questions

What sell-side analysts currently cover shares of Dolby Laboratories?

The following Wall Street analysts have issued stock ratings on Dolby Laboratories in the last year: B. Riley, Barrington Research, JPMorgan Chase & Co., TheStreet, Tigress Financial, and Zacks Investment Research.
View the latest analyst ratings for DLB.

What is the current price target for Dolby Laboratories?

3 Wall Street analysts have set twelve-month price targets for Dolby Laboratories in the last year. Their average twelve-month price target is $79.00, suggesting a possible downside of 20.7%. B. Riley has the highest price target set, predicting DLB will reach $89.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $65.00 for Dolby Laboratories in the next year.
View the latest price targets for DLB.

What is the current consensus analyst rating for Dolby Laboratories?

Dolby Laboratories currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DLB will outperform the market and that investors should add to their positions of Dolby Laboratories.
View the latest ratings for DLB.

What other companies compete with Dolby Laboratories?

Other companies that are similar to Dolby Laboratories include Amphenol, Corning, Littelfuse, Vishay Intertechnology and Rogers.

How do I contact Dolby Laboratories' investor relations team?

Dolby Laboratories' physical mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker's listed phone number is (415) 558-0200 and its investor relations email address is [email protected] The official website for Dolby Laboratories is www.dolby.com.

NYSE:DLB - Dolby Laboratories Stock Price Target and Predictions

Analyst Price Target for DLB

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Dolby Laboratories?

What is the current price target for Dolby Laboratories?

What is the current consensus analyst rating for Dolby Laboratories?

What other companies compete with Dolby Laboratories?

How do I contact Dolby Laboratories' investor relations team?